CDC50B

CDC50B (TMEM30B) is a two-transmembrane, endoplasmic reticulum-resident accessory subunit that selectively partners with class 1 P4-ATPase phospholipid flippases to enforce membrane lipid asymmetry (PMID:17948906, PMID:20947505, PMID:37293153). It physically associates with ATP8B1 and ATP8B2 — but not ATP8B4, ATP8A1, or ATP8A2 — and this interaction is mutually required for ER exit and stability of both partners, with the P4-ATPase subunit dictating the final localization of the complex (PMID:20947505). Functionally, CDC50B coexpression relocalizes ATP8B1 from the ER to the plasma membrane and markedly increases inward phosphatidylserine translocation while reducing outer-leaflet PS exposure (PMID:17948906). Cryo-EM of the ATP8B1–CDC50B complex shows CDC50B serving as a noncatalytic auxiliary partner that stabilizes an autoinhibited state released upon phospholipid substrate binding, with bile acids facilitating this release (PMID:35349344). The complex has a defined physiological role in cochlear outer hair cells, where the Tmem30b–Atp8b1 pair localizes to stereocilia and the cuticular plate to maintain phospholipid asymmetry; loss of Tmem30b causes phosphatidylserine externalization, stereocilia disorganization, hair-cell degeneration, and early-onset hearing loss that is reversible by AAV-mediated Tmem30b delivery (PMID:42054370). Beyond its flippase chaperone role, CDC50B is a direct transcriptional target of CREB3L1 and supports protein synthesis and secretion during odontoblast differentiation (PMID:39384739).

1. 2008 High

   Established that CDC50B is not merely a sequence homolog but a functional accessory protein that traffics a P4-ATPase out of the ER and enables its flippase activity, defining its core role.

   Evidence Heterologous coexpression in CHO cells with fluorescent lipid translocation and annexin V PS-exposure assays

   PMID:17948906

   Open questions at the time

   • Did not test specificity against other P4-ATPases
   • Mechanism of how CDC50B promotes ER exit not resolved
2. 2010 High

   Defined the partner selectivity and mutual dependence of the interaction, showing CDC50B binds ATP8B1/ATP8B2 specifically and that the P4-ATPase, not CDC50B, sets complex localization.

   Evidence Co-IP with a panel of P4-ATPases and subcellular localization imaging in heterologous cells

   PMID:20947505

   Open questions at the time

   • Did not establish stoichiometry or structural basis of selectivity
   • Endogenous interactions not confirmed
3. 2011 High

   Delimited CDC50B function by showing it is insufficient as a beta-subunit for ATP8A2, with chimera swaps pinpointing CDC50A's transmembrane and exocytoplasmic domains as the determinants of that incompatibility.

   Evidence Co-IP and chimeric domain-swap mutagenesis with lipid transport assay in HEK293T cells

   PMID:21454556

   Open questions at the time

   • Why CDC50B cannot substitute structurally remained undefined at the time
   • Did not address physiological tissue-specific pairing
4. 2022 High

   Provided structural mechanism, showing CDC50B acts as a noncatalytic auxiliary subunit stabilizing an autoinhibited ATP8B1 state that is relieved by substrate and bile acids.

   Evidence Cryo-EM structure determination of ATP8B1 with CDC50A and CDC50B plus substrate-binding analysis

   PMID:35349344

   Open questions at the time

   • Functional consequence of autoinhibition release in cells not quantified
   • Whether CDC50B vs CDC50A confer distinct regulatory properties not resolved
5. 2023 Medium

   Confirmed CDC50B is an ER-localized membrane protein with both termini cytoplasmic, anchoring its topology and subcellular compartment experimentally.

   Evidence Overexpression, subcellular fractionation, and topology assays in HEK293 and HK-2 cells

   PMID:37293153

   Open questions at the time

   • Single-lab topology determination
   • ER residence under endogenous conditions not shown
6. 2024 Medium

   Extended CDC50B function beyond flippase chaperoning by placing it in a CREB3L1 secretory program, where it supports protein synthesis and secretion during odontoblast differentiation.

   Evidence ATAC-seq, RNA-seq, Tmem30b knockout in mDPCs, and overexpression rescue in CREB3L1-deficient cells

   PMID:39384739

   Open questions at the time

   • Molecular link between flippase activity and secretion not established
   • Rescue was only partial
7. 2026 High

   Demonstrated an in vivo physiological requirement: the Tmem30b–Atp8b1 complex maintains stereocilia lipid asymmetry, and its loss causes hearing loss rescuable by gene delivery, including cross-rescue of Atp8b1 mutants.

   Evidence Tmem30b knockout mice, dynamic localization imaging, AAV rescue, and ABR auditory testing

   PMID:42054370

   Open questions at the time

   • Mechanism linking lipid asymmetry loss to stereocilia disorganization not detailed
   • Relevance to human hearing loss not directly tested
8. 2026 Medium

   Reinforced the OHC role by tying TMEM30B/ATP8B1 expression to mechanoelectrical transduction onset and showing loss causes PS externalization and rapid hair-cell degeneration.

   Evidence Conditional knockout mice, ABR, immunofluorescence, and PS-externalization assays (preprint)

   PMID:41726979

   Open questions at the time

   • Preprint, not peer-reviewed
   • Overlaps with the same year's published study; independent confirmation pending

• How CDC50B selectivity for ATP8B1/ATP8B2, its ER-exit chaperone role, and its CREB3L1-linked secretory function are mechanistically integrated, and whether human CDC50B mutations cause disease, remain open.
• No human disease-causing mutation reported in the corpus
• Connection between flippase activity and protein secretion unresolved
• Tissue-specific partner choice mechanism unknown